Literature DB >> 15556124

Antidepressant treatment of co-occurring depression and alcohol dependence.

Helen M Pettinati1.   

Abstract

The use of antidepressant pharmacotherapy to treat patients with co-occurring depression and alcohol dependence is controversial. There is a stigma attached to giving medications to alcohol-dependent persons. Also, empirical evidence is sparse and inconsistent, which discourages the use of antidepressants in these patients. Historically, it has been a challenge to accurately diagnose a depressive disorder in the presence of alcohol dependence. In addition, early clinical studies were fraught with methodological problems; however, improved diagnostic assessments are now available, and in the last decade, results from well-controlled trials appear to support the use of antidepressants in this patient population in the specific role of relieving depressive symptoms. The majority of these trials also demonstrate that antidepressants have relatively little impact on reducing heavy drinking in this patient population, even though the medications reduce depressive symptoms. Newer approaches to treating patients with co-occurring depression and alcohol dependence suggest adding to the antidepressant a pharmacotherapy that directly impacts drinking. The findings from this review better define the action of antidepressants in patients with co-occurring depression and alcohol dependence as specific to reducing depressive symptoms, and these medications and their action on mood have little impact on treating the co-occurring alcohol dependence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15556124     DOI: 10.1016/j.biopsych.2004.07.016

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  42 in total

1.  Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence.

Authors:  Samuel W Centanni; Bridget D Morris; Joseph R Luchsinger; Gaurav Bedse; Tracy L Fetterly; Sachin Patel; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2018-11-02       Impact factor: 7.853

2.  The Validity of the Montgomery-Asberg Depression Rating Scale in an Inpatient Sample with Alcohol Dependence.

Authors:  Breanne Hobden; Melanie L Schwandt; Mariko Carey; Mary R Lee; Mehdi Farokhnia; Sofia Bouhlal; Christopher Oldmeadow; Lorenzo Leggio
Journal:  Alcohol Clin Exp Res       Date:  2017-05-22       Impact factor: 3.455

3.  Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence.

Authors:  Jennifer D J Hobbs; Matt G Kushner; Susanne S Lee; Sean M Reardon; Eric W Maurer
Journal:  Am J Addict       Date:  2011-05-31

Review 4.  Treatment of substance abusing patients with comorbid psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley; Antoine B Douaihy
Journal:  Addict Behav       Date:  2011-09-14       Impact factor: 3.913

5.  Inhibition of AMPA receptor and CaMKII activity in the lateral habenula reduces depressive-like behavior and alcohol intake in rats.

Authors:  Jing Li; Seungwoo Kang; Rao Fu; Liangzhi Wu; Wei Wu; Hongwei Liu; Danielle Gregor; Wanhong Zuo; Alex Bekker; Jiang-Hong Ye
Journal:  Neuropharmacology       Date:  2017-08-31       Impact factor: 5.250

Review 6.  Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder.

Authors:  Gaurav Bedse; Samuel W Centanni; Danny G Winder; Sachin Patel
Journal:  Alcohol Clin Exp Res       Date:  2019-08-21       Impact factor: 3.455

Review 7.  Current status of co-occurring mood and substance use disorders: a new therapeutic target.

Authors:  Helen M Pettinati; Charles P O'Brien; William D Dundon
Journal:  Am J Psychiatry       Date:  2013-01       Impact factor: 18.112

8.  Abstinence following alcohol drinking produces depression-like behavior and reduced hippocampal neurogenesis in mice.

Authors:  Jennie R Stevenson; Jason P Schroeder; Kimberly Nixon; Joyce Besheer; Fulton T Crews; Clyde W Hodge
Journal:  Neuropsychopharmacology       Date:  2008-06-18       Impact factor: 7.853

Review 9.  Exercise training - A beneficial intervention in the treatment of alcohol use disorders?

Authors:  Mark Stoutenberg; Chad D Rethorst; Olivia Lawson; Jennifer P Read
Journal:  Drug Alcohol Depend       Date:  2015-11-22       Impact factor: 4.492

10.  Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology.

Authors:  Kaitlin T Warnock; Andrew R S T Yang; Heon S Yi; Harry L June; Timothy Kelly; Anthony S Basile; Phil Skolnick; Harry L June
Journal:  Pharmacol Biochem Behav       Date:  2012-11       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.